Boiron SA (FRA:BON)

Market Cap	310.78M -35.6%
Revenue (ttm)	495.78M -1.8%
Net Income	26.19M +35.2%
EPS	1.51 +35.2%
Shares Out	n/a
PE Ratio	11.67
Forward PE	n/a
Dividend	1.35 (7.67%)
Ex-Dividend Date	Jun 3, 2026

Volume	120
Open	17.60
Previous Close	17.55
Day's Range	17.60 - 17.60
52-Week Range	16.50 - 31.35
Beta	n/a
Analysts	n/a
Price Target	n/a
Est. Earnings	Oct 28, 2026

About Boiron

Boiron SA manufactures and sells homeopathic medicines in France, rest of Europe, North America, and internationally. The company offers homeopathic medicines and homeopathic specialties; and other healthcare products, including medical devices (in vitro diagnostics), dietary supplements, herbal remedies, cosmetics, and CBD-based products. It also provides homeopathic specialties comprising Oscillococcinum to treat influenza symptoms, such as fever, chills, headaches, and aches; Stodal and Stodaline for treating coughs; Arnigel for adjunctive l...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1932
• Employees: 2,623
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: BON

Financial Performance

In 2025, Boiron's revenue was 501.11 million, an increase of 2.78% compared to the previous year's 487.56 million. Earnings were 32.64 million, an increase of 187.96%.

Data Sources: S&P Global Market Intelligence and Twelve Data

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Twelve Data.

Last checked:

Oct 26, 2026

Data Sources Report a data error